Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 107
Filtrar
1.
Neuropsychol Rev ; 34(1): 192-213, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36806051

RESUMO

Olfactory and gustatory dysfunction have been reported in mild and major neurocognitive disorders (NCDs), with variable results. While olfactory dysfunction has been consistently explored, reports on gustatory alterations are limited. We systematically reviewed case-control studies evaluating gustatory function in NCDs with various etiologies and different neuropathology. Eighteen studies were included in the systematic review, and eight were included in the meta-analysis. Most studies were on Alzheimer's disease (AD) and Parkinson's disease (PD). Pooled analyses showed worse global taste threshold and identification (sour in particular) scores in AD than controls and worse global, sweet, and sour scores in AD compared to mild cognitive impairment (MCI). PD with MCI showed worse global, sweet, salty, and sour scores than controls and cognitively unimpaired PD. Taste dysfunction was differentially associated with the severity of cognitive deficits. Gustatory dysfunction may represent a potential cross-disease chemosensory biomarker of NCD. Whether gustatory alterations may be a pre-clinical biomarker of NCD requires further studies.


Assuntos
Doença de Alzheimer , Disfunção Cognitiva , Doença de Parkinson , Distúrbios do Paladar , Humanos , Doença de Alzheimer/complicações , Biomarcadores , Doença de Parkinson/complicações , Olfato , Paladar , Distúrbios do Paladar/complicações
2.
Quintessence Int ; 54(10): 852-866, 2023 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-37581371

RESUMO

This paper is aimed at comprehensively reviewing olfactory and gustatory disorders caused by SARS-CoV-2 in children and adults. An electronic and manual search was done on three databases: MEDLINE, Embase, and Web of Science. Inclusion criteria included publications written in English, involving humans in the age range of 0 to 99 years that were captured by a controlled vocabulary of thesaurus terms. Olfactory and gustatory disorders rates in COVID-19 ranged from 22% to 71.9% in adults and 16.6% to 25.8% in children. Olfactory and gustatory disorders might appear as the first symptom, and in adults might even be the only symptom (4.8% to 10%). Anosmia is the most common olfactory disorder and hypogeusia is the most common gustatory disorder. In 33% to 89% of cases, olfactory and gustatory disorders resolve spontaneously within a few weeks, coinciding with the resolution of other COVID-19 symptoms, both in adults and children. However, in some patients, olfactory and gustatory disorders persist beyond the resolution of other symptoms. Notably, children generally experience a swifter and more favorable recovery compared to adults. The precise pathogenesis underlying olfactory and gustatory disorders in the context of COVID-19 remains unclear and is likely multifactorial. Presently, no established treatment protocol exists for olfactory and gustatory disorders and current treatments reviewed lack robust evidence and are not readily available for clinical use. Olfactory training represents the only therapy currently recommended by international authorities. Pediatric practitioners and general dental practitioners should be aware of olfactory and gustatory disorders in both pediatric and adult populations, including their biologic mechanisms, treatment options, and recovery rates.


Assuntos
COVID-19 , Transtornos do Olfato , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Adulto Jovem , COVID-19/complicações , Odontólogos , Transtornos do Olfato/etiologia , Transtornos do Olfato/diagnóstico , Papel Profissional , SARS-CoV-2 , Distúrbios do Paladar/complicações
3.
In Vivo ; 37(4): 1894-1900, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37369461

RESUMO

BACKGROUND/AIM: Dysgeusia, one of the adverse effects of cancer chemotherapy, and anorexia due to taste disorder can significantly impair the quality of life of patients. However, an evaluation method for dysgeusia has not yet been established. The present prospective study aimed to utilize a combination of subjective and objective assessment methods to evaluate dysgeusia in patients with gastrointestinal cancer initiating chemotherapy, to determine chemotherapeutic drugs and regimens causing dysgeusia, and to assess whether dysgeusia was associated with zinc deficiency. PATIENTS AND METHODS: A total of 21 patients with newly diagnosed gastrointestinal cancer were registered between August 2020 to March 2021. The following regimens were also included in the evaluation if the patients did not develop dysgeusia. A total 30 regimens were administered to the patients during the study period. A salt-impregnated test paper (Salsave®) was used as a subjective assessment, and the chemotherapy-induced taste alteration scale was used as an objective assessment. RESULTS: Based on physician interviews, dysgeusia was diagnosed in 8 of 21 patients (38%) treated with 8 of 30 regimens (27%). All regimens that resulted in dysgeusia contained platinum-based drugs. The patients who developed dysgeusia had higher controlling nutritional status scores at the start of chemotherapy compared to those who did not develop dysgeusia. In both subjective and objective assessments, the patients with dysgeusia performed significantly worse than those without dysgeusia. Six of the eight patients who developed dysgeusia were administered Novelzine, which did not improve the taste disorder despite the improvement of serum zinc levels. CONCLUSION: The combined approach using subjective and objective taste assessment methods was useful in assessing chemotherapy-induced dysgeusia. Mechanisms other than hypozincemia should be considered as contributors to taste disorders caused by platinum-based drugs.


Assuntos
Antineoplásicos , Neoplasias Gastrointestinais , Humanos , Disgeusia/induzido quimicamente , Disgeusia/tratamento farmacológico , Projetos Piloto , Qualidade de Vida , Estudos Prospectivos , Antineoplásicos/efeitos adversos , Neoplasias Gastrointestinais/complicações , Neoplasias Gastrointestinais/tratamento farmacológico , Distúrbios do Paladar/induzido quimicamente , Distúrbios do Paladar/complicações , Distúrbios do Paladar/tratamento farmacológico , Zinco
4.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 54(2): 334-341, 2023 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-36949695

RESUMO

The taste buds in the human tongue contain specialized cells that generate taste signals when they are stimulated. These signals are then transmitted to the central nervous system, allowing the human body to distinguish nutritious substances from toxic or harmful ones. This process is critical to the survival of humans and other mammals. A number of studies have shown that dysgeusia, or taste disorder, is a common complication of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which can severely affect patients' nutritional intake and quality of life. Based on the physiological process of taste perception, the direct causes of dysgeusia include dysfunction of taste receptors and damage to the taste nervous system, while indirect causes include genetic factors, aging-related changes, bacterial and viral infections, and cancer treatments such as radiotherapy and chemotherapy. The pathogenic factors of dysgeusia are complicated, further research is needed to fully understand the underlying mechanisms, and some of the reported findings and conclusions still need further validation. All these form a great challenge for clinical diagnosis of the cause and targeted treatment of dysgeusia. Herein, we reviewed published research on the physiological process of taste perception, the potential mechanisms of taste disorders related to SARS-CoV-2 infection, and strategies for prevention and treatment, providing theoretical support for establishing and improving the comprehensive management of COVID-19 complicated by taste disorders.


Assuntos
COVID-19 , Transtornos do Olfato , Humanos , COVID-19/complicações , Disgeusia/etiologia , Disgeusia/terapia , Percepção Gustatória , SARS-CoV-2 , Paladar/fisiologia , Qualidade de Vida , Olfato , Transtornos do Olfato/complicações , Distúrbios do Paladar/terapia , Distúrbios do Paladar/complicações
5.
Pediatr Neurol ; 136: 28-33, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36084419

RESUMO

INTRODUCTION: Anosmia and hypogeusia are frequent symptoms in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adults, but their incidence in children is unknown. OBJECTIVE: Describe the incidence and associated characteristics of olfactory and gustatory dysfunction in children with SARS-CoV-2 infection. MATERIAL AND METHODS: Descriptive study carried out by telephone survey of patients aged between five and 18 years with SARS-CoV-2 infection confirmed between March and December, 2020. RESULTS: Two hundred eighty Spanish patients (female: 42.2%) with a mean age of 10.4 years (±3.54, range: 5 to 17) were analyzed, 22.5% with other diseases (mostly respiratory: 11.8%). The most frequent symptoms were fever (55.36%) and neurological symptoms (45.7%). Forty-four (15.7%) were hospitalized due to the infection, in intensive care unit (ICU): 7.1%. Forty-five patients (16.1%) had anosmia and/or hypogeusia: 32 both, eight with hypogeusia only, and five with exclusively anosmia. The mean symptom duration in days for anosmia was 36.4, and for hypogeusia it was 27.6. Either symptom was the initial manifestation in 15 patients. None had anosmia/hypogeusia with no other symptoms. Anosmia/hypogeusia was related to the presence of respiratory infection, gastroenteritis, chills, odynophagia, myalgia, asthenia, and anorexia, but not severity (hospitalization/ICU admission). Cohabitation with another infected individual was associated with a higher incidence of anosmia/hypogeusia (P = 0.041) and duration of anosmia (P = 0.006). The presence of anosmia/hypogeusia in cohabitants was associated with longer duration of anosmia (P < 0.001). CONCLUSIONS: The incidence of anosmia/hypogeusia in children with SARS-CoV-2 was lower than that reported in adults, although with a longer duration. Although no association was found between anosmia/hypogeusia and greater disease severity, recognition of these symptoms could help identify paucisymptomatic patients.


Assuntos
Ageusia , COVID-19 , Transtornos do Olfato , Adolescente , Adulto , Ageusia/epidemiologia , Ageusia/etiologia , Anosmia , COVID-19/complicações , Criança , Pré-Escolar , Feminino , Humanos , Transtornos do Olfato/diagnóstico , Transtornos do Olfato/epidemiologia , Transtornos do Olfato/etiologia , SARS-CoV-2 , Olfato , Distúrbios do Paladar/complicações , Distúrbios do Paladar/etiologia
6.
Artigo em Chinês | MEDLINE | ID: mdl-35822377

RESUMO

Objective:To analyze the etiology and clinical features of patients with olfactory disorders (OD) , and to explore the importance of gustatory testing in patients with OD. Methods:Clinical data of 335 consecutive patients with OD who seek medical consultation in the smell and taste center from the year 2015 to 2021 was retrospectively analyzed. The clinical characteristics of patients with OD were analyzed thorough a structured interview of medical history, otolaryngologic examinations, olfactory tests(Sniffin' Sticks test) and gustatory function test(whole-mouth taste test). SPSS 17.0 software was used to analyze the clinical characteristics of patients with OD and related factors which have effect on gustatory function. Results:Among the patients, 36.4% of them caused by head trauma, 22.1% for upper respiratory tract infection(URTI), 15.5% for rhinosinusitis diseases(RSD), 11.9% for idiopathic, 9.6% for congenital anosmia, and 4.5% for other causes, respectively. The features were different in patients with different kinds of OD: most patients with head trauma were anosmic(χ²=27.958, P<0.001), and no difference was found in gender and age(P>0.05 for both); most patients with URTI were anosmic(χ²=21.568, P<0.001), and female patients were more than male(χ²=5.898, P<0.05), elder patients were more than younger(χ²=12.963, P<0.001); most patients with RSD were anosmic(χ²=12.106, P<0.05), and male patients were more than female(χ²=4.655, P<0.05); elder patients were more than younger for idiopathic OD(χ²=5.284, P<0.05), but no sex difference was found(P>0.05); patients with congenital anosmia were all lost their smell since they were born, and no sex difference was found in the disease(P>0.05). Fifty-seven of 146(39%) patients whose gustation was assessed had gustatory dysfunction. Gustatory function was significantly associated with the causes of OD(r=0.368, P<0.05), but not related to olfactory function, age and sex(P>0.05 for all). Conclusion:The leading causes of olfactory dysfunction were head trauma, URTI, RSD, and idiopathic causes. Each of OD had its own distinct clinical features. Gustatory dysfunction were common in patients with OD, and gustatory function was related to the causes of OD. High priority should be given to gustatory function evaluation for the patients with OD.


Assuntos
Traumatismos Craniocerebrais , Transtornos do Olfato , Adulto , Idoso , Traumatismos Craniocerebrais/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos do Olfato/congênito , Transtornos do Olfato/etiologia , Estudos Retrospectivos , Distúrbios do Paladar/complicações
7.
Brain Nerve ; 74(7): 873-878, 2022 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-35860934

RESUMO

Olfactory and taste dysfunctions are characteristic symptoms of coronavirus disease 2019 (COVID-19); however, their frequencies and pathogeneses keep changing because of rapid mutations of the viral strains. Angiotensin-converting enzyme 2, a receptor for the spike protein of SARS-CoV-2 in the olfactory epithelium, is involved in the development of olfactory dysfunction. In general, olfactory dysfunctions resolve in a few weeks. However, there are cases wherein the symptoms persist for several months or longer, and parosmia or phantosmia affects the patient's quality of life. It is also assumed that the damage owing to COVID-19 extends to olfactory nerve cells, resulting in sensorineural olfactory dysfunction similar to post-infectious olfactory dysfunction.


Assuntos
COVID-19 , Transtornos do Olfato , COVID-19/complicações , Humanos , Transtornos do Olfato/diagnóstico , Transtornos do Olfato/etiologia , Qualidade de Vida , SARS-CoV-2 , Olfato/fisiologia , Paladar , Distúrbios do Paladar/complicações
8.
J Biophotonics ; 15(8): e202200058, 2022 08.
Artigo em Inglês | MEDLINE | ID: mdl-35445797

RESUMO

It is postulated that the inflammatory process resulting from SARS-CoV-2 infection is the main cause of smell and taste dysfunctions in patients. In view of this, photobiomodulation, due to its anti-inflammatory and antioxidant effects, may be a promising therapeutic modality to treat these disorders. In the present case report, we observed clinical improvement in the symptoms of anosmia and ageusia related to COVID-19 after treatment with photobiomodulation. Due to the inflammatory nature of COVID-19 and the anti-inflammatory effects, photobiomodulation antioxidants already proven in the literature make it a promising therapeutic modality, especially sequela COVID-related, including olfactory (anosmia) and taste (ageusia) dysfunction. In the present case report, the patient's olfactory and gustatory functions were re-established after 10 treatment sessions with photobiomodulation.


Assuntos
Ageusia , COVID-19 , Terapia com Luz de Baixa Intensidade , Transtornos do Olfato , Ageusia/etiologia , Anosmia , COVID-19/complicações , COVID-19/radioterapia , Humanos , Transtornos do Olfato/complicações , SARS-CoV-2 , Olfato , Distúrbios do Paladar/complicações
9.
J Clin Neurosci ; 100: 52-58, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35398594

RESUMO

The purpose of this study is to determine the volumes of primary brain regions associated with smell and taste in Alzheimer's and Parkinson's patients and healthy controls using MR imaging and examine volumetric changes in comparison to smell/taste questionnaire and test results and endocannabinoid (EC) levels. The study included 15 AD patients with mild cognitive dysfunction scored as 18 ≤ MMSE ≤ 23, 15 PD patients with scores of 18 < MoCA < 26 and 18 ≤ MMSE ≤ 23, and 15 healthy controls. A taste and smell questionnaire was given to the participants, and their taste and smell statuses were examined using the Sniffin' Sticks smell identification test and Burghart Taste Strips. EC levels were analyzed in the blood serum samples of the participants using the ELISA method. The volumes of the left olfactory bulb (p = 0.001), left amygdala (p = 0.004), left hippocampus (p = 0.008), and bilateral insula (left p = 0.000, right p = 0.000) were significantly smaller in the Alzheimer's patients than the healthy controls. The volumes of the left olfactory bulb (p = 0.001) and left hippocampus (p = 0.009) were significantly smaller in the Parkinson's patients than the healthy controls. A significant correlation was determined between volume reduction in the left Rolandic operculum cortical region and taste dysfunction. EC levels were significantly higher in both AD (p = 0.000) and PD (p = 0.006) in comparison to the controls. Our results showed that volumetric changes occur in the brain regions associated with smell and taste in Alzheimer's and Parkinson's patients. It was observed that ECs played a role in these volumetric changes and the olfactory and taste dysfunctions of the patients.


Assuntos
Doença de Alzheimer , Transtornos do Olfato , Doença de Parkinson , Doença de Alzheimer/complicações , Doença de Alzheimer/diagnóstico por imagem , Endocanabinoides , Humanos , Transtornos do Olfato/complicações , Transtornos do Olfato/etiologia , Bulbo Olfatório/diagnóstico por imagem , Doença de Parkinson/complicações , Doença de Parkinson/diagnóstico por imagem , Olfato , Paladar , Distúrbios do Paladar/complicações , Distúrbios do Paladar/etiologia
10.
Ir J Med Sci ; 191(4): 1759-1766, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34562193

RESUMO

BACKGROUND: Smell and taste dysfunctions (STDs) are symptoms associated with COVID-19 syndrome, even if their incidence is still uncertain and variable. AIMS: In this study, the effects of SARS-CoV-2 infection on chemosensory function have been investigated using both a self-reporting questionnaire on smell and flavor perception, and a simplified flavor test. METHODS: A total of 111 subjects (19 hospitalized [HOS] and 37 home-isolated [HI] COVID-19 patients, and 55 healthy controls [CTRL]) were enrolled in the study. They received a self-evaluation questionnaire and a self-administered flavor test kit. The flavor test used consists in the self-administration of four solutions with a pure olfactory stimulus (coffee), a mixed olfactory-trigeminal stimulus (peppermint), and a complex chemical mixture (banana). RESULTS: After SARS-CoV-2 infection, HOS and HI patients reported similar prevalence of STDs, with a significant reduction of both smell and flavor self-estimated perception. The aromas of the flavor test were recognized by HI and HOS COVID-19 patients similarly to CTRL; however, the intensity of the perceived aromas was significantly lower in patients compared to controls. CONCLUSION: Data reported here suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified "flavor test" could be a novel self-administering objective screening test to assess STDs in COVID-19 patients. CLINICAL TRIAL REGISTRATION NO: NCT04840966; April 12, 2021, retrospectively registered.


Assuntos
COVID-19 , Transtornos do Olfato , Estudos de Casos e Controles , Humanos , Transtornos do Olfato/diagnóstico , Transtornos do Olfato/etiologia , SARS-CoV-2 , Olfato , Distúrbios do Paladar/complicações
11.
Nutr Rev ; 80(5): 1086-1093, 2022 04 08.
Artigo em Inglês | MEDLINE | ID: mdl-34338769

RESUMO

Zinc supplementation is indicated for diarrhea and taste disorders, which are both features of COVID-19 . Nevertheless, this strategy has not been tested for the treatment of these secondary complications in the current pandemic. Through an updated review, a practical appraisal was considered as a means of providing a medical nexus of therapeutic zinc regimens as an adjunct in the management of COVID-19-related diarrhea and ageusia/dysgeusia. While diarrhea and taste disorders are consequences of COVID-19, zinc supplementation is useful for non-COVID-19 patients with these clinical problems. The overwhelming evidence for supplementing with zinc in diarrhea and pneumonia is associated with the treatment of children, while for taste disorders the use of supplementing with zinc is more examined in adults. Whereas COVID-19 is more prevalent in adults, precautions should be exercised not to translate the zinc dosage used for children with diarrhea and taste disorders into the current pandemic. Therapeutic doses of zinc used for adults (∼50-150 mg/day of elemental zinc) could be included in the treatment strategies for COVID-19, but this proposal should be examined through randomized studies.


Assuntos
Ageusia , Tratamento Farmacológico da COVID-19 , Adulto , Ageusia/complicações , Ageusia/tratamento farmacológico , Criança , Diarreia/tratamento farmacológico , Suplementos Nutricionais , Disgeusia/tratamento farmacológico , Disgeusia/etiologia , Humanos , Distúrbios do Paladar/complicações , Distúrbios do Paladar/tratamento farmacológico , Zinco/uso terapêutico
12.
Am J Otolaryngol ; 42(4): 103001, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33773440

RESUMO

OBJECTIVE: The association between COVID-19 and chemosensory loss has garnered substantial attention, however to date little is known about the real-life consequences of impairment in this unique patient population. The aim of this study is to evaluate the quality of life (QOL) and personal safety deficits experienced by patients with COVID-19 infection. STUDY DESIGN: Prospective, longitudinal questionnaires. SETTING: National survey. METHODS: A longitudinal web-based nationwide survey of adults with COVID-19 and/or a sudden change in smell and taste was launched April 10, 2020. Previously published questions on chemosensory-related QOL and safety events were asked at the 6-month follow-up survey. RESULTS: As of February 10, 2021, 480 eligible respondents took the 6-month questionnaire, of whom 322 were COVID-19 positive. Impact on QOL was substantial with 96% of subjects reporting at least one of the defined deficits, and over 75% reporting at least 3 of these. "Reduced enjoyment of food" was the most common complaint (87%), while 43% of subjects self-reported depression. The prevalence of safety-related issues was common in this population, with over 57% reporting at least one, and 36% reporting 2 or more events. Of the events asked, the inability to smell smoke that others could perceive was the most common at 45%. CONCLUSIONS: COVID-19 associated chemosensory losses have a real and substantial impact on both quality of life and safety, beyond mere inconvenience. The high prevalence of these issues despite a relatively short period of olfactory deficit should alert clinicians to the serious risks to an already vulnerable patient population.


Assuntos
COVID-19/complicações , Transtornos do Olfato/complicações , Qualidade de Vida , Distúrbios do Paladar/complicações , Adolescente , Adulto , Idoso , Feminino , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Transtornos do Olfato/psicologia , Transtornos do Olfato/virologia , Estudos Prospectivos , Risco , Inquéritos e Questionários , Distúrbios do Paladar/psicologia , Distúrbios do Paladar/virologia , Adulto Jovem
13.
Curr Allergy Asthma Rep ; 21(2): 6, 2021 02 03.
Artigo em Inglês | MEDLINE | ID: mdl-33537862

RESUMO

PURPOSE OF REVIEW: Chemosensory dysfunction in the patients with COVID-19 has been reported frequently in the studies from different regions of the world. However, the prevalence of smell and/or taste disorders presents significant ethnic and geographic variability. In addition, the pathogenesis of chemosensory dysfunction remains unclarified. RECENT FINDINGS: This is a narrative review on the recent state of the prevalence, mechanism, and diagnostic and therapeutic strategy of chemosensory dysfunction in COVID-19 patients during the global pandemic. The chemosensory dysfunction was analysis based on recent studies, which either used questionnaires, Likert scales (0-10), or smell tests to estimate the smell and taste dysfunction. The ethnic and geographic difference of the prevalence of smell and/or taste disorders and the potential underlying mechanisms have been discussed. Several suggestions on the diagnosis and treatment of COVID-19 patients with smell and taste disorders were summarized for the physicians. This review provides a comprehensive overview of the current studies regarding the chemosensory dysfunction during the COVID-19 worldwide outbreak.


Assuntos
COVID-19/epidemiologia , Transtornos do Olfato/complicações , SARS-CoV-2 , Distúrbios do Paladar/complicações , COVID-19/complicações , COVID-19/etnologia , Demografia , Etnicidade , Saúde Global , Humanos , Pandemias , Prevalência , Inquéritos e Questionários
14.
Expert Rev Mol Diagn ; 21(2): 245-250, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33496627

RESUMO

Introduction: This study aimed to assess the correlation between nucleic acid amplification test (real-time reverse transcription-polymerase chain reaction, RT-PCR) positivity of patients presenting with suspected COVID-19 and pneumonic infiltration consistent with COVID-19-specific pneumonia diagnosis on thoracic computed tomography (CT), with symptoms, laboratory findings, and clinical progression.Methods: The study included 286 patients (female:male 131:155; mean age, 53.3 ± 17.9 years) who were divided into two groups according to their RT-PCR test results. The symptoms, laboratory examinations, clinical findings, and thoracic CT imaging of the patients were evaluated.Results: While the physical examination, comorbidities, and total CT scores were similar between the groups, taste/smell abnormalities were observed more frequently in the PCR-positive group. The use of moxifloxacin, lopinavir/ritonavir, and tocilizumab was higher in the PCR-positive group (p = 0.016, p < 0.001, and p = 0.002, respectively). The duration of hospitalization, intensive care requirement, and mortality rate of the studied groups did not differ between the groups.Conclusions: Among patients presenting with suspected COVID-19 and pneumonic infiltration consistent with COVID-19 on thoracic CT, the symptoms, physical examination, total CT scores, duration of hospitalization, intensive care requirement, and mortality rate were similar between RT-PCR-positive and RT-PCR-negative patients. However, PCR-positive patients appeared to require more specific treatments.


Assuntos
Teste de Ácido Nucleico para COVID-19 , COVID-19/diagnóstico por imagem , COVID-19/mortalidade , Reação em Cadeia da Polimerase em Tempo Real , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais Humanizados/uso terapêutico , Comorbidade , Feminino , Humanos , Lopinavir/uso terapêutico , Masculino , Pessoa de Meia-Idade , Moxifloxacina/uso terapêutico , Transtornos do Olfato/complicações , Radiografia Torácica , Ritonavir/uso terapêutico , Distúrbios do Paladar/complicações , Tomografia Computadorizada por Raios X , Turquia/epidemiologia , Tratamento Farmacológico da COVID-19
15.
J Ren Nutr ; 31(1): 49-56, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32773236

RESUMO

OBJECTIVE: Gustatory function is frequently impaired in patients with chronic kidney disease (CKD), and the associated taste dysfunction contributes to compromised nutrition. Whether gustatory dysfunction is an underappreciated risk factor for frailty in patients with CKD remains unclear. The objective of this work was to examine the role of gustatory dysfunction as a risk factor for frailty in patients with CKD. METHODS: We prospectively enrolled patients with stage 3 or higher CKD from a single institute, with their gustatory function assessed using both objective (taste strip method) and subjective approaches, and frailty identified using the Edmonton frail scale, FRAIL scale, and Study of Osteoporotic Fracture (SOF) scale. Multiple regression analyses were performed to investigate whether results from gustatory function tests independently correlated with frailty. RESULTS: Among the enrolled patients with CKD, 14 (17.9%) were found to be frail. We discovered that higher taste strip scores, or better taste function, were significantly associated with a lower frail probability (odds ratio [OR] 0.74 per score, 95% confidence interval [CI] 0.57-0.97), independent of clinical features, while better subjective taste function (OR 0.84 per score, 95% CI 0.74-0.96) and better oral cavity intactness (OR, 0.94; 95% CI, 0.9-0.98) were similarly associated with a lower frail probability among patients with CKD. CONCLUSION: Gustatory dysfunction may be an important risk factor for frailty in patients with CKD. It is tempting to presume that interventions aiming to ameliorate such deficits may bear the potential of reducing frailty severity in this population with a high frailty burden.


Assuntos
Idoso Fragilizado/estatística & dados numéricos , Avaliação Geriátrica/métodos , Insuficiência Renal Crônica/complicações , Distúrbios do Paladar/complicações , Idoso , Estudos de Coortes , Feminino , Humanos , Masculino , Estudos Prospectivos , Fatores de Risco , Distúrbios do Paladar/diagnóstico
16.
J Acad Nutr Diet ; 121(3): 435-445, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-32828739

RESUMO

BACKGROUND: Small clinical studies have suggested that individuals with insufficient sleep could experience taste dysfunction. However, this notion has not been examined in a large-scale, population-based study. OBJECTIVE: This study aimed to examine whether overall sleep quality, as assessed by insomnia, daytime sleepiness, snoring, and sleep duration, was associated with the odds of having altered taste perception in a large population-based study. DESIGN: This was a cross-sectional study that used data from a subcohort of the Kailuan study, an ongoing multicenter cohort study that began in 2006 in Tangshan City, China. PARTICIPANTS/SETTING: The participants were 11,030 adults aged 25 years or older (mean age 53.7 ± 10.7 years), who were free of neurodegenerative diseases. All the participants had undergone questionnaire assessments and medical examinations at Kailuan General Hospital from June 2012 to October 2013. MAIN OUTCOME MEASURES: Altered taste and olfactory perception were assessed via a questionnaire with two questions regarding whether participants had any problems with sense of taste or smell for ≥3 months. STATISTICAL ANALYSES PERFORMED: The association between sleep quality and altered taste/olfactory perception was examined using a logistic regression model, adjusting for age, sex, lifestyle factors (eg, obesity, smoking, alcohol intake, and physical activity) and health status (eg, lipid profiles, blood pressure, modification use, and presence of chronic diseases). RESULTS: Poor overall sleep quality was associated with a higher risk of having altered taste perception (adjusted odds ratio for low vs high sleep quality 2.03, 95% CI 1.42 to 2.91; P < 0.001). Specifically, insomnia, daytime sleepiness, and short sleep duration, but not prolonged sleep duration and snoring, were significantly associated with altered taste perception. A significant association between overall sleep quality and the risk of having altered olfactory perception was also observed (adjusted odds ratio for low vs high sleep quality 2.17, 95% CI 1.68 to 2.80; P < 0.001). CONCLUSIONS: In this population-based study, poor sleep quality was associated with a high likelihood of altered taste perception.


Assuntos
Transtornos do Olfato/epidemiologia , Transtornos Intrínsecos do Sono/epidemiologia , Distúrbios do Paladar/epidemiologia , Adulto , China/epidemiologia , Estudos de Coortes , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Transtornos do Olfato/complicações , Percepção Olfatória/fisiologia , Transtornos Intrínsecos do Sono/complicações , Transtornos Intrínsecos do Sono/fisiopatologia , Distúrbios do Início e da Manutenção do Sono/epidemiologia , Inquéritos e Questionários , Distúrbios do Paladar/complicações , Percepção Gustatória/fisiologia
17.
Toxins (Basel) ; 12(6)2020 06 25.
Artigo em Inglês | MEDLINE | ID: mdl-32630499

RESUMO

Patients with chronic kidney disease (CKD) have an increased risk of vascular calcification (VC), including aortic arch calcification (AAC). Few investigated the influence of gustatory function on the probability of having VC. We examined whether gustatory function results modulated the probability of having VC in patients with CKD. We prospectively enrolled adults with CKD (estimated glomerular filtration rate <60 mL/min/1.73 m2), with their AAC rated semi-quantitatively and gustatory function assessed by objective and subjective approaches. Multiple logistic regression was used to analyze the relationship between gustatory function results and AAC. Those with AAC had significantly better objective gustatory function in aggregate scores (p = 0.039) and categories (p = 0.022) and less defective bitter taste (p = 0.045) and scores (p = 0.037) than those without. Multiple regression analyses showed that higher aggregate scores (odds ratio (OR) 1.288, p = 0.032), or better gustatory function, and higher bitter taste scores (OR 2.558, p = 0.019) were each associated with a higher probability of having AAC among CKD patients; such an association was modulated by serum phosphate levels. In conclusion, better gustatory function was independently correlated with having AAC among CKD patients. A follow-up of VC severity may be an underrecognized component of care for CKD patients with a preserved gustatory function.


Assuntos
Fosfatos/sangue , Insuficiência Renal Crônica/complicações , Distúrbios do Paladar/complicações , Paladar , Uremia/complicações , Calcificação Vascular/etiologia , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/fisiopatologia , Medição de Risco , Fatores de Risco , Distúrbios do Paladar/sangue , Distúrbios do Paladar/fisiopatologia , Uremia/sangue , Uremia/fisiopatologia , Calcificação Vascular/sangue , Calcificação Vascular/fisiopatologia
18.
J Ren Nutr ; 30(5): 368-379, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-31983590

RESUMO

One of the most disabling, yet neglected, symptom of patients with chronic kidney disease (CKD) is alteration in taste. The purpose of this review is to examine the extent and content of research around this symptom in CKD with the goals of (1) identifying gaps in current research knowledge and (2) guiding future research. The review summarizes the basic anatomy and physiology of taste followed by analysis of the epidemiology, pathophysiology, and management strategies for taste changes in patients with CKD.


Assuntos
Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/fisiopatologia , Distúrbios do Paladar/fisiopatologia , Distúrbios do Paladar/terapia , Humanos , Paladar , Distúrbios do Paladar/complicações
19.
Handb Clin Neurol ; 164: 325-360, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31604557

RESUMO

A number of neurodegenerative diseases are accompanied by disordered smell function. The degree of dysfunction can vary among different diseases, such that olfactory testing can aid in differentiating, for example, Alzheimer's disease (AD) from major affective disorder and Parkinson's disease (PD) from progressive supranuclear palsy. Unfortunately, altered smell function often goes unrecognized by patients and physicians alike until formal testing is undertaken. Such testing uniquely probes brain regions not commonly examined in physical examinations and can identify, in some cases, patients who are already in the "preclinical" stage of disease. Awareness of this fact is one reason why the Quality Standards Committee of the American Academy of Neurology has designated smell dysfunction as one of the key diagnostic criteria for PD. The same recommendation has been made by the Movement Disorder Society for both the diagnosis of PD and identification of prodromal PD. Similar suggestions are proposed to include olfactory dysfunction as an additional research criterion for the diagnosis of AD. Although taste impairment, i.e., altered sweet, sour, bitter, salty, and umami perception, has also been demonstrated in some disorders, taste has received much less scientific attention than smell. In this review, we assess what is known about the smell and taste disorders of a wide range of neurodegenerative diseases and describe studies seeking to understand their pathologic underpinnings.


Assuntos
Doenças Neurodegenerativas/fisiopatologia , Transtornos do Olfato/fisiopatologia , Olfato/fisiologia , Distúrbios do Paladar/fisiopatologia , Doença de Alzheimer/complicações , Doença de Alzheimer/fisiopatologia , Humanos , Doenças Neurodegenerativas/complicações , Transtornos do Olfato/complicações , Doença de Parkinson/complicações , Doença de Parkinson/fisiopatologia , Distúrbios do Paladar/complicações
20.
Neurol Sci ; 40(2): 399-404, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30515604

RESUMO

The primary aim of the study is to evaluate possible taste changes in a cohort of amyotrophic lateral sclerosis patients (pALS) with dysphagia, focusing on eventual psychological and quality of life (QoL) implications. The second aim is to evaluate the changes of QoL following the use of a specific device that provides food flavour. Thirty-two ALS patients were recruited and divided into two groups: subjects feeding only through enteral tube (ET) and subjects still eating by oral way (OW). A specific set of questionnaires was selected and adapted to investigate possible changes of taste and the impact on psychological status and QoL. Moreover, a specific device that provides food flavours in a safety manner was applied to all patients. We found a perceived reduction of taste in ALS patients, in particular in the ET group. All patients showed a strong interest in the preservation of taste, and its loss negatively related to their QoL. The use of the flavour device improved the perceived QoL showing no side effects, even in the ET group. For the first time, our study revealed changes in taste perception in a cohort of ALS patients and the negative consequences that these changes have on psychological status and QoL. Furthermore, the positive effects of the device used to provide flavours suggest a possible rehabilitative effect, which should be better evaluated and confirmed in further studies.


Assuntos
Esclerose Lateral Amiotrófica/complicações , Transtornos de Deglutição/complicações , Qualidade de Vida , Distúrbios do Paladar/complicações , Esclerose Lateral Amiotrófica/fisiopatologia , Esclerose Lateral Amiotrófica/psicologia , Esclerose Lateral Amiotrófica/reabilitação , Estudos de Coortes , Transtornos de Deglutição/fisiopatologia , Transtornos de Deglutição/psicologia , Transtornos de Deglutição/reabilitação , Nutrição Enteral , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Distúrbios do Paladar/fisiopatologia , Distúrbios do Paladar/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA